Predictors of Spontaneous Bacterial Peritonitis Among Patients with Cirrhosis
NCT06884306 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-03-19
Summary
Prevalence of spontaneous bacterial peritonitis (SBP) varies from approximately 4% among asymptomatic patients to 30% among those hospitalized \[1, 2\].Previous studies explored the role of several biomarkers, such as tumor necrosis factor-α, procalcitonin, and fecal calprotectin, for prediction of SBP The NLR is speculated to reflect immune regulatory mechanism (lymphocytes) and ongoing inflammation (neutrophils) . Assessing the diagnostic value of NLR for liver disease has gained particular interest, namely, among patients with nonalcoholic fatty liver disease and hepatocellular carcinoma . Direct interaction between platelets and bacteria lead to platelet activation . Platelet activation leads to change of platelet shape with increase in platelet size and anisocytosis, and consequent increase in both mean platelet volume (MPV) and platelet distribution width (PDW) .Acute phase reactants, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), are elevated among patients with SBP, as a result of cytokine synthesis . Older patients, due to higher possibility of advanced liver disease and more frequent comorbidity, are more susceptible to SBP .
The Department of Tropical Medicine (Mansoura University) developed a simple scoring system for prediction of SBP among cirrhotic patients with ascites, which include four variables: age, MPV, NLR, and C-reactive protein (CRP) . The independent predictors of SBP were age of at least 55 years, MPV of at least 8.5 fL, NLR of at least 2.5, and CRP of at least 40 mg/dL . The progression of hospitalized patients with SBP can lead to an in-hospital mortality rate of approximately 17% .
Therefore, the sequelae of SBP highlight the increasing value of establishing reliable diagnostic biomarkers. The earlier the diagnosis, the lower the mortality rate.To our knowledge, only one, national study utilized MPV, NLR, and CRP for prediction of SBP among cirrhotic patients with ascites \[3\].We intend to further extend both the diagnostic utilities (by adding ESR to the previously mentioned tools) and the spectrum of prediction, to include mortality in addition to the development of SBP among cirrhotic patients with ascites.
The study aims at developing a local scoring system (RSS) for the prediction of SBP and its related mortality among cirrhotic patients with ascites admitted to Al-Rajhy Liver Hospital (Assiut University).
Our objective is to compare age, NLR, MPV, PDW, and CRP between cirrhotic patients with ascites complicated with SBP and those without SBP, and between surviving SBP patients compared to those with in-hospital mortality.
Conditions
- Cirrhosis
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2026-05-01
- Completion
- 2026-07-01
More Related Trials
-
Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis
NCT04195724 ·Status: UNKNOWN ·Phase: NA
-
Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis
NCT05641025 ·Status: COMPLETED
-
CMV Reactivation in Acute Necrotizing Pancreatitis
NCT05898048 ·Status: COMPLETED
-
Study of New Biological Markers for Prediction of Severe Acute Pancreatitis
NCT00786591 ·Status: COMPLETED
-
Liver Cirrhosis Network Cohort Study
NCT05740358 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis
NCT03693586 ·Status: COMPLETED
-
Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients
NCT03965260 ·Status: COMPLETED
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease
NCT07284862 ·Status: COMPLETED
-
Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
NCT01200082 ·Status: TERMINATED
-
A Study of the Intestinal Microbiome in Patients with Cirrhosis
NCT06808698 ·Status: NOT_YET_RECRUITING
-
Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease
NCT03868332 ·Status: UNKNOWN
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Prognosis of SRD Patients in the ICU
NCT04398381 ·Status: COMPLETED
-
CRP /albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients
NCT06750315 ·Status: NOT_YET_RECRUITING
-
Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation
NCT00528138 ·Status: COMPLETED
-
Clinical Usefulness of Cortisol, Antinuclear Antibodies and High-sensitivity C-reactive Protein in Acute Pancreatitis
NCT03830060 ·Status: UNKNOWN
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Study of the Clinical Features of Autoimmune Hepatitis
NCT02994537 ·Status: UNKNOWN
-
Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene
NCT03830073 ·Status: UNKNOWN
-
Neutrophil/Lymphocyte Ratio in Acute Pancreatitis
NCT05859633 ·Status: UNKNOWN
-
Prevalence of H.Pylori in CKD Patients
NCT05882968 ·Status: UNKNOWN
-
The Circulating Fibrocyte - a Novel and Accurate Biomarker in Diagnosing Acute Appendicitis in Adults
NCT03988660 ·Status: COMPLETED
-
Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis
NCT05473403 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis
NCT05565885 ·Status: RECRUITING